Biotech Values

[JJM760]

You may just get your opportunity. Obviously I hope you don't. I think it's pretty cheap right now and this IS your opportunity. I also don't take Merck's silence on Rida as some have. I think that's just their S.O.P.

Aria's pipeline may not be majestic as Dew pointed out, but it is pretty damn good. They have 2 years of cash and the possibility of 2 drugs on the market next year (Pona may end up being a blockbuster). They most likely will have some big cash infusions in the form of the $25 mil Merck milestone @ Rida NDA and some sort of Pona regional partnership (I would be speculating if I guessed at what that would be worth).

But for what ever reason, this company seems to always attract pessimism and you may end up being right.